Logo image of CNDT

CONDUENT INC (CNDT) Stock Fundamental Analysis

USA - NASDAQ:CNDT - US2067871036 - Common Stock

2.48 USD
-0.19 (-7.12%)
Last: 10/10/2025, 9:18:35 PM
2.5 USD
+0.02 (+0.81%)
After Hours: 10/10/2025, 9:18:35 PM
Fundamental Rating

2

Overall CNDT gets a fundamental rating of 2 out of 10. We evaluated CNDT against 86 industry peers in the IT Services industry. CNDT has a bad profitability rating. Also its financial health evaluation is rather negative. CNDT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CNDT had negative earnings in the past year.
CNDT had a negative operating cash flow in the past year.
In the past 5 years CNDT reported 4 times negative net income.
Of the past 5 years CNDT 4 years had a positive operating cash flow.
CNDT Yearly Net Income VS EBIT VS OCF VS FCFCNDT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B

1.2 Ratios

CNDT has a Return On Assets of 0.40%. This is comparable to the rest of the industry: CNDT outperforms 45.35% of its industry peers.
CNDT's Return On Equity of 1.09% is in line compared to the rest of the industry. CNDT outperforms 50.00% of its industry peers.
Industry RankSector Rank
ROA 0.4%
ROE 1.09%
ROIC N/A
ROA(3y)0.32%
ROA(5y)-0.6%
ROE(3y)-5.14%
ROE(5y)-5.6%
ROIC(3y)N/A
ROIC(5y)N/A
CNDT Yearly ROA, ROE, ROICCNDT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

With a Profit Margin value of 0.32%, CNDT perfoms like the industry average, outperforming 43.02% of the companies in the same industry.
CNDT has a worse Gross Margin (17.96%) than 86.05% of its industry peers.
In the last couple of years the Gross Margin of CNDT has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 0.32%
GM 17.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.32%
GM growth 5Y-3.05%
CNDT Yearly Profit, Operating, Gross MarginsCNDT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

3

2. Health

2.1 Basic Checks

CNDT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CNDT has been reduced compared to 1 year ago.
CNDT has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CNDT has been reduced compared to a year ago.
CNDT Yearly Shares OutstandingCNDT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CNDT Yearly Total Debt VS Total AssetsCNDT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of 0.11, we must say that CNDT is in the distress zone and has some risk of bankruptcy.
CNDT has a Altman-Z score of 0.11. This is amonst the worse of the industry: CNDT underperforms 80.23% of its industry peers.
A Debt/Equity ratio of 0.68 indicates that CNDT is somewhat dependend on debt financing.
CNDT has a Debt to Equity ratio of 0.68. This is in the lower half of the industry: CNDT underperforms 60.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Altman-Z 0.11
ROIC/WACCN/A
WACC9.04%
CNDT Yearly LT Debt VS Equity VS FCFCNDT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

CNDT has a Current Ratio of 1.65. This is a normal value and indicates that CNDT is financially healthy and should not expect problems in meeting its short term obligations.
CNDT has a Current ratio (1.65) which is in line with its industry peers.
A Quick Ratio of 1.65 indicates that CNDT should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.65, CNDT perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.65
CNDT Yearly Current Assets VS Current LiabilitesCNDT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

More info and screens

3

3. Growth

3.1 Past

CNDT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -89.66%.
CNDT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.36%.
Measured over the past years, CNDT shows a decrease in Revenue. The Revenue has been decreasing by -5.56% on average per year.
EPS 1Y (TTM)-89.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.14%
Revenue 1Y (TTM)-14.36%
Revenue growth 3Y-6.76%
Revenue growth 5Y-5.56%
Sales Q2Q%-8.94%

3.2 Future

Based on estimates for the next years, CNDT will show a very strong growth in Earnings Per Share. The EPS will grow by 42.80% on average per year.
CNDT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.90% yearly.
EPS Next Y44.1%
EPS Next 2Y42.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-7.05%
Revenue Next 2Y-1.53%
Revenue Next 3Y6.9%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CNDT Yearly Revenue VS EstimatesCNDT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
CNDT Yearly EPS VS EstimatesCNDT Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CNDT. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 121.57, which means the current valuation is very expensive for CNDT.
CNDT's Price/Forward Earnings is on the same level as the industry average.
CNDT is valuated expensively when we compare the Price/Forward Earnings ratio to 22.57, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 121.57
CNDT Price Earnings VS Forward Price EarningsCNDT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CNDT is valued cheaper than 90.70% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.44
CNDT Per share dataCNDT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CNDT does not grow enough to justify the current Price/Earnings ratio.
CNDT's earnings are expected to grow with 42.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.8%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CNDT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CONDUENT INC

NASDAQ:CNDT (10/10/2025, 9:18:35 PM)

After market: 2.5 +0.02 (+0.81%)

2.48

-0.19 (-7.12%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)10-29 2025-10-29
Inst Owners75.63%
Inst Owner Change0%
Ins Owners9.17%
Ins Owner Change2.97%
Market Cap391.77M
Analysts86.67
Price Target7.17 (189.11%)
Short Float %2.62%
Short Ratio3.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.05
Dividend Growth(5Y)2.53%
DP100%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.94%
Min EPS beat(2)12.1%
Max EPS beat(2)17.77%
EPS beat(4)3
Avg EPS beat(4)-5.52%
Min EPS beat(4)-63.4%
Max EPS beat(4)17.77%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.3%
Min Revenue beat(2)-5.4%
Max Revenue beat(2)-3.2%
Revenue beat(4)0
Avg Revenue beat(4)-3.73%
Min Revenue beat(4)-5.4%
Max Revenue beat(4)-3.13%
Revenue beat(8)3
Avg Revenue beat(8)-1.59%
Revenue beat(12)3
Avg Revenue beat(12)-1.64%
Revenue beat(16)3
Avg Revenue beat(16)-1.64%
PT rev (1m)0%
PT rev (3m)1.08%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.14%
EPS NY rev (1m)1.72%
EPS NY rev (3m)-3.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.2%
Revenue NY rev (1m)-0.53%
Revenue NY rev (3m)-1.6%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 121.57
P/S 0.13
P/FCF N/A
P/OCF N/A
P/B 0.43
P/tB 3.04
EV/EBITDA 6.44
EPS(TTM)-0.55
EYN/A
EPS(NY)0.02
Fwd EY0.82%
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS19.7
BVpS5.82
TBVpS0.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.4%
ROE 1.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.32%
GM 17.96%
FCFM N/A
ROA(3y)0.32%
ROA(5y)-0.6%
ROE(3y)-5.14%
ROE(5y)-5.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.32%
GM growth 5Y-3.05%
F-Score3
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Debt/EBITDA 5.23
Cap/Depr 25.67%
Cap/Sales 1.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.65
Quick Ratio 1.65
Altman-Z 0.11
F-Score3
WACC9.04%
ROIC/WACCN/A
Cap/Depr(3y)43.07%
Cap/Depr(5y)40.25%
Cap/Sales(3y)2.71%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-89.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.14%
EPS Next Y44.1%
EPS Next 2Y42.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.36%
Revenue growth 3Y-6.76%
Revenue growth 5Y-5.56%
Sales Q2Q%-8.94%
Revenue Next Year-7.05%
Revenue Next 2Y-1.53%
Revenue Next 3Y6.9%
Revenue Next 5YN/A
EBIT growth 1Y-286.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year625.83%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-720%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-135.43%
OCF growth 3YN/A
OCF growth 5YN/A